BI
Biogen Inc
🇩🇪XETR.IDPGermanyHealthcare
€165.68EURup +4.14 (+2.56%)Pre-marketEnd of day6:33 AM
Price€165.68+4.14 (+2.56%)
Profile
- Healthcare
- Drug Manufacturers - General
- Germany
Identity
- Exchange
- Xetra . XETR
- Type
- Stock
- ISIN
- US09062X1037
- CUSIP
- Not reported
Company
- Employees
- 7,500
- Headquarters
- Cambridge, United States
- Website
- https://www.biogen.com
- CEO
- Mr. Christopher A. Viehbacher
Market
- Shares outstanding
- 147.6M
- Market cap
- €24.46B
Highlights
- Market cap
- €24.46B
- EPS LTM
- $5.62
- P/E LTM
- 38.12
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $9.95B-0.49%down year on year
- Net income
- $835.09M-45.44%down year on year
- Gross margin
- 67.71%-6.65%down year on year
- Free cash flow
- $2.97B+59.89%up year on year
Other listings
- XSTU.IDPStuttgart Stock Exchange
- XNAS.BIIBNasdaq
- XFRA.IDPFrankfurt Stock Exchange
- XMEX.BIIBMexican Stock Exchange
- BVMF.BIIB34B3 - Brasil Bolsa Balcão
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.